$KHOB
KHEOBA CORP.

2024 Q2 Form 10-Q Financial Statement

#000147793224003623 Filed on June 11, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q4
Revenue $0.00 $10.30K
YoY Change -100.0%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $292.00
YoY Change
% of Gross Profit
Operating Expenses $10.86K $6.601K
YoY Change 981.87%
Operating Profit -$10.86K $3.699K
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax $0.00
% Of Pretax Income
Net Earnings -$10.86K $3.699K
YoY Change -229.37%
Net Earnings / Revenue 35.91%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 8.092M shares 7.820M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $1.385K $30.87K $16.78K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $13.00K
Receivables
Other Receivables
Total Short-Term Assets $30.87K $29.78K
YoY Change 1385.19%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $15.63K $2.917K
YoY Change -16.66%
TOTAL ASSETS
Total Short-Term Assets $30.87K $29.78K
Total Long-Term Assets $15.63K $2.917K
Total Assets $35.64K $46.50K $32.70K
YoY Change 493.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $0.00 $2.537K
YoY Change -43.62%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.370K $10.21K
YoY Change 15.07%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.370K $10.21K
Total Long-Term Liabilities
Total Liabilities
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$16.58K -$5.713K -$9.412K
YoY Change 0.5%
Common Stock $8.092K $7.295K
YoY Change 21.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $31.27K $42.13K $22.49K
YoY Change
Total Liabilities & Shareholders Equity $46.50K $32.70K
YoY Change 493.91%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q4
OPERATING ACTIVITIES
Net Income -$10.86K $3.699K
YoY Change -229.37%
Depreciation, Depletion And Amortization $292.00
YoY Change
Cash From Operating Activities $11.15K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$13.00K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $15.10K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $15.94K
YoY Change
NET CHANGE
Cash From Operating Activities $11.15K
Cash From Investing Activities -$13.00K
Cash From Financing Activities $15.94K
Net Change In Cash $14.09K
YoY Change
FREE CASH FLOW
Cash From Operating Activities $11.15K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Revenues
Revenues
0 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
dei Entity Central Index Key
EntityCentralIndexKey
0001909770
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--10-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7295000 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-04-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
333-263020
dei Entity Registrant Name
EntityRegistrantName
KHEOBA CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1636812
dei Entity Address Address Line1
EntityAddressAddressLine1
Petonal el Cerezo 8
dei Entity Address Address Line2
EntityAddressAddressLine2
2A Los Realejos
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
38410
dei Entity Address City Or Town
EntityAddressCityOrTown
Tenerife
dei Entity Address Country
EntityAddressCountry
ES
dei City Area Code
CityAreaCode
702
dei Local Phone Number
LocalPhoneNumber
833-9604
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8092000 shares
CY2024Q2 us-gaap Cash
Cash
1385 usd
CY2023Q4 us-gaap Cash
Cash
16778 usd
CY2024Q2 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
20000 usd
CY2023Q4 us-gaap Prepaid Expense Current And Noncurrent
PrepaidExpenseCurrentAndNoncurrent
13000 usd
CY2023Q4 kheo Due To Related Party Current
DueToRelatedPartyCurrent
4370 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10207 usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 usd
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8092000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7295000 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
7295 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24605 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9412 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
22488 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32695 usd
CY2023Q2 us-gaap Revenues
Revenues
9400 usd
us-gaap Revenues
Revenues
10300 usd
us-gaap Revenues
Revenues
9400 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10862 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1004 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17463 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1004 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
10862 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
1004 usd
us-gaap Operating Expenses
OperatingExpenses
17463 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-10862 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
8396 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-10862 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
8396 usd
us-gaap Net Income Loss
NetIncomeLoss
-7163 usd
us-gaap Net Income Loss
NetIncomeLoss
8396 usd
CY2024Q2 kheo Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.00
CY2023Q2 kheo Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
0.00
kheo Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
-0.00
kheo Basic And Diluted Earnings Per Share
BasicAndDilutedEarningsPerShare
0.00
CY2024Q2 kheo Basic And Diliuted Weighted Average Number Of Shares Outstanding
BasicAndDiliutedWeightedAverageNumberOfSharesOutstanding
8092000 shares
CY2023Q2 kheo Basic And Diliuted Weighted Average Number Of Shares Outstanding
BasicAndDiliutedWeightedAverageNumberOfSharesOutstanding
6000000 shares
kheo Basic And Diliuted Weighted Average Number Of Shares Outstanding
BasicAndDiliutedWeightedAverageNumberOfSharesOutstanding
8037712 shares
kheo Basic And Diliuted Weighted Average Number Of Shares Outstanding
BasicAndDiliutedWeightedAverageNumberOfSharesOutstanding
6000000 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3365 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
0 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-3365 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
8396 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
5031 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
22488 usd
CY2024Q1 kheo Common Shares Issued For Cash Amount
CommonSharesIssuedForCashAmount
15940 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
3699 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
42127 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-10862 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
31265 usd
us-gaap Net Income Loss
NetIncomeLoss
-7163 usd
us-gaap Net Income Loss
NetIncomeLoss
8396 usd
us-gaap Depreciation
Depreciation
1667 usd
us-gaap Depreciation
Depreciation
0 usd
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
3300 usd
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
0 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-7000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2537 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-4500 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-18333 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3896 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
13000 usd
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15940 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15940 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
0 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-15393 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
3896 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16778 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2005 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1385 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5901 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16575 usd
us-gaap Revenues
Revenues
10300 usd
CY2024Q2 kheo Due To Related Party Current
DueToRelatedPartyCurrent
4370 usd
CY2023Q4 us-gaap Share Price
SharePrice
0.02
CY2023Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
42000 shares
CY2023Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
840 usd
CY2023Q4 us-gaap Share Price
SharePrice
0.02
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2024Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3300 usd
CY2023Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
755000 shares
CY2023Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
15100 usd
CY2024Q2 us-gaap Revenues
Revenues
0 usd
CY2023Q2 us-gaap Revenues
Revenues
9400 usd
us-gaap Revenues
Revenues
10300 usd
us-gaap Revenues
Revenues
9400 usd
kheo Loanfromdirectortextblock
LOANFROMDIRECTORTEXTBLOCK
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>NOTE 4 – <em>LOAN FROM DIRECTOR</em></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As of April 30, 2024, the Company owed $4,370 to the Company’s sole director, Gaga Gvenetadze for the Company’s working capital purposes. The amount is outstanding and payable upon request.</p>
CY2024Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
427000 shares
CY2023Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8540 usd
CY2023Q3 us-gaap Share Price
SharePrice
0.02
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8092000 shares
us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
16575 usd
CY2023 us-gaap Income Tax Expense Benefit Continuing Operations Adjustment Of Deferred Tax Asset Liability
IncomeTaxExpenseBenefitContinuingOperationsAdjustmentOfDeferredTaxAssetLiability
9412 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-16575 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-9412 usd
us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
0 usd
CY2023 us-gaap Tax Adjustments Settlements And Unusual Provisions
TaxAdjustmentsSettlementsAndUnusualProvisions
0 usd
CY2024Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3481 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
1977 usd
CY2024Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3481 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1977 usd
CY2024Q1 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 usd
CY2024Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
16575 usd

Files In Submission

Name View Source Status
0001477932-24-003623-index-headers.html Edgar Link pending
0001477932-24-003623-index.html Edgar Link pending
0001477932-24-003623.txt Edgar Link pending
0001477932-24-003623-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kheo-20240430.xsd Edgar Link pending
kheo_10q.htm Edgar Link pending
kheo_ex311.htm Edgar Link pending
kheo_ex321.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
kheo_10q_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
kheo-20240430_cal.xml Edgar Link unprocessable
kheo-20240430_lab.xml Edgar Link unprocessable
kheo-20240430_def.xml Edgar Link unprocessable
kheo-20240430_pre.xml Edgar Link unprocessable